These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31128515)

  • 1. Film-nanoparticle composite for enhanced oral delivery of alpha-casozepine.
    Castro PM; Baptista P; Zuccheri G; Madureira AR; Sarmento B; Pintado ME
    Colloids Surf B Biointerfaces; 2019 Sep; 181():149-157. PubMed ID: 31128515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of PLGA nanoparticles with mucoadhesive guar-gum films for buccal delivery of antihypertensive peptide.
    Castro PM; Baptista P; Madureira AR; Sarmento B; Pintado ME
    Int J Pharm; 2018 Aug; 547(1-2):593-601. PubMed ID: 29800740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incorporation of beads into oral films for buccal and oral delivery of bioactive molecules.
    Castro PM; Sousa F; Magalhães R; Ruiz-Henestrosa VMP; Pilosof AMR; Madureira AR; Sarmento B; Pintado ME
    Carbohydr Polym; 2018 Aug; 194():411-421. PubMed ID: 29801856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of PLGA nanoparticles loaded with clofazimine for oral delivery: Assessment of formulation variables and intestinal permeability.
    Chaves LL; Costa Lima SA; Vieira ACC; Barreiros L; Segundo MA; Ferreira D; Sarmento B; Reis S
    Eur J Pharm Sci; 2018 Jan; 112():28-37. PubMed ID: 29122712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption.
    Sheng J; Han L; Qin J; Ru G; Li R; Wu L; Cui D; Yang P; He Y; Wang J
    ACS Appl Mater Interfaces; 2015 Jul; 7(28):15430-41. PubMed ID: 26111015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration.
    Zhang X; Sun M; Zheng A; Cao D; Bi Y; Sun J
    Eur J Pharm Sci; 2012 Apr; 45(5):632-8. PubMed ID: 22248882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface decorated nanoparticles as surrogate carriers for improved transport and absorption of epirubicin across the gastrointestinal tract: Pharmacokinetic and pharmacodynamic investigations.
    Tariq M; Alam MA; Singh AT; Panda AK; Talegaonkar S
    Int J Pharm; 2016 Mar; 501(1-2):18-31. PubMed ID: 26812610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and in vitro evaluation of thienorphine-loaded PLGA nanoparticles.
    Yang Y; Xie XY; Mei XG
    Drug Deliv; 2016; 23(3):787-93. PubMed ID: 24870204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing insulin oral absorption by using mucoadhesive nanoparticles loaded with LMWP-linked insulin conjugates.
    Sheng J; He H; Han L; Qin J; Chen S; Ru G; Li R; Yang P; Wang J; Yang VC
    J Control Release; 2016 Jul; 233():181-90. PubMed ID: 27178809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PLGA nanoparticles loaded with beta-lactoglobulin-derived peptides modulate mucosal immunity and may facilitate cow's milk allergy prevention.
    Kostadinova AI; Middelburg J; Ciulla M; Garssen J; Hennink WE; Knippels LMJ; van Nostrum CF; Willemsen LEM
    Eur J Pharmacol; 2018 Jan; 818():211-220. PubMed ID: 29079360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced oral bioavailability of insulin using PLGA nanoparticles co-modified with cell-penetrating peptides and Engrailed secretion peptide (Sec).
    Zhu S; Chen S; Gao Y; Guo F; Li F; Xie B; Zhou J; Zhong H
    Drug Deliv; 2016 Jul; 23(6):1980-91. PubMed ID: 26181841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioavailability enhancement, Caco-2 cells uptake and intestinal transport of orally administered lopinavir-loaded PLGA nanoparticles.
    Joshi G; Kumar A; Sawant K
    Drug Deliv; 2016 Nov; 23(9):3492-3504. PubMed ID: 27297453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of CSK-DEX-PLGA Nanoparticles for the Oral Delivery of Exenatide to Improve Its Mucus Penetration and Intestinal Absorption.
    Song Y; Shi Y; Zhang L; Hu H; Zhang C; Yin M; Chu L; Yan X; Zhao M; Zhang X; Mu H; Sun K
    Mol Pharm; 2019 Feb; 16(2):518-532. PubMed ID: 30601014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral insulin delivery, the challenge to increase insulin bioavailability: Influence of surface charge in nanoparticle system.
    Czuba E; Diop M; Mura C; Schaschkow A; Langlois A; Bietiger W; Neidl R; Virciglio A; Auberval N; Julien-David D; Maillard E; Frere Y; Marchioni E; Pinget M; Sigrist S
    Int J Pharm; 2018 May; 542(1-2):47-55. PubMed ID: 29501738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Transport of PLGA nanoparticles across Caco-2/HT29-MTX co-cultured cells].
    Wen Z; Li G; Lin DH; Wang JT; Qin LF; Guo GP
    Yao Xue Xue Bao; 2013 Dec; 48(12):1829-35. PubMed ID: 24689242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genipin-structured peptide-polysaccharide nanoparticles with significantly improved resistance to harsh gastrointestinal environments and their potential for oral delivery of polyphenols.
    Hu B; Xie M; Zhang C; Zeng X
    J Agric Food Chem; 2014 Dec; 62(51):12443-52. PubMed ID: 25479066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of borneol on the pharmacokinetics of 9-nitrocamptothecin encapsulated in PLGA nanoparticles with different size via oral administration.
    Ru G; Han L; Qing J; Sheng J; Li R; Qiu M; Wang J
    Drug Deliv; 2016 Nov; 23(9):3417-3423. PubMed ID: 27174642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel PLGA-based nanoparticles for the oral delivery of insulin.
    Malathi S; Nandhakumar P; Pandiyan V; Webster TJ; Balasubramanian S
    Int J Nanomedicine; 2015; 10():2207-18. PubMed ID: 25848248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucoadhesive chitosan-coated PLGA nanoparticles for oral delivery of ferulic acid.
    Lima IA; Khalil NM; Tominaga TT; Lechanteur A; Sarmento B; Mainardes RM
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):993-1002. PubMed ID: 29842790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
    Feng SS; Mei L; Anitha P; Gan CW; Zhou W
    Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.